` 603079 (Zhejiang Shengda Bio-Pharm Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

Z
603079
vs
S
Shanghai Composite

Over the past 12 months, Zhejiang Shengda Bio-Pharm Co Ltd has outperformed Shanghai Composite, delivering a return of +34% compared to the Shanghai Composite's +23% growth.

Stocks Performance
603079 vs Shanghai Composite

Loading
603079
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
603079 vs Shanghai Composite

Loading
603079
Shanghai Composite
Difference
www.alphaspread.com

Performance By Year
603079 vs Shanghai Composite

Loading
603079
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Zhejiang Shengda Bio-Pharm Co Ltd vs Peers

Shanghai Composite
603079
JEF
JNJ
4312
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Zhejiang Shengda Bio-Pharm Co Ltd
Glance View

Market Cap
3.6B CNY
Industry
Pharmaceuticals

Zhejiang Shengda Bio-Pharm Co., Ltd. engages in the research, development, production, and sale of food and feed additives. The company is headquartered in Taizhou, Zhejiang and currently employs 1,114 full-time employees. The company went IPO on 2017-08-23. Its vitamin products mainly include biotin and folic acid. Its biological preservative products mainly include natamycin and nisin. The firm distributes its products in domestic market and to overseas markets.

Intrinsic Value
7.84 CNY
Overvaluation 59%
Intrinsic Value
Price
Z
Back to Top